Citrobacter koseri Cellulitis During Anti-CD20 Monoclonal Antibody (Ofatumumab) Treatment for B-cell Chronic Lymphocytic Leukaemia

被引：6
|
作者：
Kluger, Nicolas [1 ]
Cartron, Guillaume [2 ]
Bessis, Didier [1 ]
Guillot, Bernard [1 ]
Girard, Celine [1 ]
机构：
[1] Univ Montpellier 1, CHU Montpellier, Hop St Eloi, Dept Dermatol, FR-34295 Montpellier, France
[2] Univ Montpellier 1, CHU Montpellier, Hop Lapeyronie, Dept Haematol, FR-34295 Montpellier, France
来源：
ACTA DERMATO-VENEREOLOGICA | 2010年 / 90卷 / 01期
关键词：
GRAM-NEGATIVE FOLLICULITIS; DIVERSUS;
D O I：
10.2340/00015555-0762
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [41] Chimeric monoclonal anti-CD20 antibody (rituximab) - an effective treatment for a patient with relapsing hairy cell leukaemia
    Hagberg, H
    MEDICAL ONCOLOGY, 1999, 16 (03) : 221 - 222
  • [42] Chimeric monoclonal anti-CD20 antibody (rituximab)—an effective treatment for a patient with relapsing hairy cell leukaemia
    H Hagberg
    Medical Oncology, 1999, 16 : 221 - 222
  • [43] Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia
    Rezvany, Mohammad Reza
    Tehrani, Mahmood Jeddi
    Karlsson, Claes
    Lundin, Jeanette
    Rabbani, Hodjattallah
    Osterborg, Anders
    Mellstedt, Hakan
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (04) : 475 - 485
  • [44] T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma
    Vincent-Salomon, A
    Mathiot, C
    MacIntyre, E
    Girre, V
    Fourquet, A
    Mercier, C
    Fréneaux, P
    Dumont, J
    Decaudin, D
    LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 387 - +
  • [45] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [46] CD20-negative relapse of cutaneous B-cell lymphoma after anti-CD20 monoclonal antibody therapy
    Massengale, WT
    McBurney, E
    Gurtler, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (03) : 441 - 443
  • [47] Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients
    Ladetto, M
    Bergui, L
    Ricca, I
    Campana, S
    Pileri, A
    Tarella, C
    MEDICAL ONCOLOGY, 2000, 17 (03) : 203 - 210
  • [48] Treatment of chronic lymphocytic leukemia (CLL)with the anti-CD20 antibody rituximab.
    Emmerich, B
    Huhn, D
    Peschel, C
    Wilhelm, M
    von Schilling, C
    Bentz, M
    Hallek, M
    Knauf, B
    Kuse, R
    Ho, AD
    BLOOD, 1999, 94 (10) : 309B - 309B
  • [49] B-cell depletion by anti-CD20 antibody treatment in rheumatoid arthritis modulates the B-cell repertoire.
    Rouzière, AS
    Kneitz, C
    Dörner, T
    Tony, HP
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S138 - S138
  • [50] Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients
    M Ladetto
    L Bergui
    I Ricca
    S Campana
    A Pileri
    C Tarella
    Medical Oncology, 2000, 17 : 203 - 210
12345